Abilify 10 Abdi Ibrahim Research Overview
Abilify 10mg by Abdi Ibrahim is an atypical antipsychotic formulation containing aripiprazole, a quinolinone derivative compound designed for in-vitro laboratory investigations. This pharmaceutical-grade preparation enables researchers to examine dopamine receptor mechanisms, particularly D2 and D3 receptor partial agonism, alongside serotonin 5-HT1A receptor interactions in controlled laboratory environments. Scientists investigating neurotransmitter modulation pathways frequently utilize this compound to analyse atypical antipsychotic mechanisms compared to traditional dopamine antagonists. Stroid UK Shop provide pharmaceutical-grade compounds for comprehensive neurological studies.
Laboratory Research Applications
Research teams studying psychopharmacology utilize aripiprazole formulations to investigate dopamine system stabilization mechanisms in cell culture models. The compound’s unique partial agonist profile at dopamine D2 receptors makes it valuable for examining dopamine modulation theories and receptor occupancy studies. Laboratory investigations often focus on the compound’s dual mechanism involving both dopaminergic and serotonergic pathways, providing insights into modern antipsychotic drug development. Researchers exploring antipsychotic drug categories frequently compare aripiprazole’s receptor binding profiles against conventional neuroleptic compounds. Studies examining metabolic side effect profiles in preclinical models utilize this compound to understand improved tolerability compared to first-generation antipsychotics.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Ingredient | Aripiprazole 10mg |
| Manufacturer | Abdi Ibrahim |
| Form | Oral tablets |
| CAS Number | 129722-12-9 |
| Molecular Formula | C₂₃H₂₇Cl₂N₃O₂ |
| Storage Conditions | Room temperature, dry environment |
Researchers investigating selective androgen receptor modulators often compare receptor selectivity mechanisms with antipsychotic compounds like aripiprazole. Additionally, studies examining peptide research applications frequently utilize pharmaceutical controls including atypical antipsychotics for comparative receptor binding analyses.
Research Compliance Statement
This product is intended strictly for in-vitro research and laboratory analysis only. Abilify 10 Abdi Ibrahim is not intended for human consumption, clinical use, or any therapeutic applications. Researchers must ensure proper laboratory protocols, appropriate safety measures, and compliance with institutional research guidelines when handling this compound. Storage should maintain pharmaceutical stability under controlled laboratory conditions. All research applications must adhere to relevant scientific and regulatory standards for laboratory chemical handling and disposal procedures.
